Ann Oncol

1. FOLPRECHT G, Stasik S, Reinacher-Schick A, Weiss L, et al
   Chemotherapy for patients with circulating tumour DNA positive, stage II colon cancer (CIRCULATE) - an AIO / ABCSG trial.
   Ann Oncol. 2026 Dec 31:S0923-7534(26)00180-8. doi: 10.1016/j.annonc.2026.
   

   >> Share

   
   
2. KOPETZ S, Tabernero J, Lonardi S, Shen L, et al
   A randomised study of encorafenib, cetuximab, and FOLFIRI versus FOLFIRI with or without bevacizumab in BRAF V600E-mutant colorectal cancer: BREAKWATER Cohort 3.
   Ann Oncol. 2026 May 31:S0923-7534(26)00179-1. doi: 10.1016/j.annonc.2026.
   

   >> Share

   
   

   
   Ann Surg Oncol

3. LI J, Cohen N
   The Jury Remains Out: The Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) Study Highlights the Need for Stringent Trials Investigating the Efficacy of Surgical Intervention.
   Ann Surg Oncol. 2026 Jun 5. doi: 10.1245/s10434-026-19942.
   

   >> Share

   
   

   
   BMC Cancer

4. PAN Y, Xiang X, Li J, Ge Y, et al
   Single-cell transcriptome analysis reveals SOX9 mutation-driven tumor stemness and microenvironment remodeling through the COL1A1-CD44 axis in colorectal cancer.
   BMC Cancer. 2026 May 30. doi: 10.1186/s12885-026-16248.
   

   >> Share

   
   
5. FAN W, Ma X
   Acetyltransferase NAT10 promotes aggressiveness of colorectal cancer cells via ac(4)C acetylation of SERPINA1 mRNA.
   BMC Cancer. 2026 May 30. doi: 10.1186/s12885-026-16215.
   

   >> Share

   
   
6. LIN YT, Chang AC, Chien CS, Lin CC, et al
   Circulating N6-methyladenosine RNA as a diagnostic and a stage-associated prognostic biomarker in colorectal cancer.
   BMC Cancer. 2026 Jun 15. doi: 10.1186/s12885-026-16290.
   

   >> Share

   
   

   
   BMC Gastroenterol

7. OH SY, Oh HH, Kim YI, Kim DH, et al
   Risk factors for residual cancer and lymph node metastasis after non-curative endoscopic resection of colorectal cancer: a multicenter retrospective study.
   BMC Gastroenterol. 2026 Jun 5. doi: 10.1186/s12876-026-04988.
   

   >> Share

   
   
8. ZHANG W, Qu L
   Construction and validation of a machine learning-based prediction model for social isolation in patients with colorectal cancer after stoma surgery.
   BMC Gastroenterol. 2026 Jun 4. doi: 10.1186/s12876-026-04974.
   

   >> Share

   
   

   
   Br J Cancer

9. RICHARDS AR, Gomez MF, Dowling BI, Bulka CM, et al
   Abundance and balance of circulating leukocyte subsets and colorectal cancer survival.
   Br J Cancer. 2026 Jun 3. doi: 10.1038/s41416-026-03480.
   

   >> Share

   
   
10. MICHAEL A, Huynh J, Sutton K, Chow MC, et al
    The utility of electronic frailty index in cancer patients undergoing chemotherapy.
    Br J Cancer. 2026;134:1793-1800.
    

    >> Share

    
    

    
    Cancer

11. LORONA NC, LaBrie S, Thomas CE, Yin H, et al
    Site- and age-dependent associations between Fusobacterium nucleatum and colorectal cancer mortality.
    Cancer. 2026;132:e70484.
    

    >> Share

    
    

    
    Cancer Lett

12. YE T, Chen M, Hu Y, Yang Z, et al
    Vesicular QSOX1-MMP2 from inflammatory cancer-associated fibroblasts degrades the extracellular matrix to drive colorectal cancer pulmonary dissemination.
    Cancer Lett. 2026 May 29:218645. doi: 10.1016/j.canlet.2026.218645.
    

    >> Share

    
    

    
    Cancer Res

13. SHE X, Lan J, Zhang H, Lu G, et al
    METTL3 Methylation Induces Decay of Endogenous Retroelement Transcripts to Promote Tumor Immune Evasion.
    Cancer Res. 2026;86:2722-2742.
    

    >> Share

    
    
14. SHI X, Chen J, Bai R, Bai H, et al
    Ribonuclease 5/Angiogenin Suppresses Intestinal Tumor Initiation by Maintaining Crypt Homeostasis.
    Cancer Res. 2026;86:2643-2659.
    

    >> Share

    
    

    
    Eur J Cancer

15. ONAY M, de Valk AF, Weigert A, Kalinauskaite G, et al
    Prognostic value of DICER and CA9 expression in patients with anal squamous cell carcinoma treated with definitive chemoradiotherapy.
    Eur J Cancer. 2026;241:116776.
    

    >> Share

    
    

    
    Hum Pathol

16. CHEN Z, Woon JY, Moetamedirad N, Islam MS, et al
    GDNF methylation is associated with pathological parameters in colorectal adenocarcinoma and the roles of circulating tumour cells.
    Hum Pathol. 2026;173:106124.
    

    >> Share

    
    

    
    Int J Colorectal Dis

17. MA H, Wang L, Song B, Chen Y, et al
    Prognostic divergence of hematogenous and lymphatic metastases in surgically treated patients with stage IV colorectal cancer.
    Int J Colorectal Dis. 2026 Jun 3. doi: 10.1007/s00384-026-05153.
    

    >> Share

    
    

    
    J Clin Oncol

18. CHAN KK, Chu RW, Cheung MC, Courneya KS, et al
    Structured exercise program following adjuvant chemotherapy for colon cancer: A cost-utility analysis of the CHALLENGE trial.
    J Clin Oncol. 2026 May 31:101200JCO2600765. doi: 10.1200/JCO-26-00765.
    

    >> Share

    
    
19. QI C, Liu C, Gong J, Wang X, et al
    Guanylyl Cyclase 2C-Targeted Chimeric Antigen Receptor T-Cell Therapy in Patients With Metastatic Colorectal Cancer.
    J Clin Oncol. 2026 Jun 4:JCO2501090. doi: 10.1200/JCO-25-01090.
    

    >> Share

    
    

    
    J Natl Cancer Inst

20. POTTER AL, Kothagundla S, Guo Q, Cheney B, et al
    Millions of adults undergoing breast and colorectal cancer screening are eligible for lung cancer screening, but do not get screened.
    J Natl Cancer Inst. 2026 Jun 5:djag176. doi: 10.1093.
    

    >> Share

    
    

    
    Oncogene

21. SU F, Zhou S, Gao Q, Lai M, et al
    High-fat diet promotes colorectal cancer via carnitine/acetylcarnitine-driven CPT1A metabolic reprogramming and the intervention of beta-hydroxybutyrate.
    Oncogene. 2026 Jun 4. doi: 10.1038/s41388-026-03835.
    

    >> Share

    
    
22. WANG Y, Wei Y, Bailey C, Peng G, et al
    HIF-1alpha integrates lipogenic FASN and glycolytic GLUT3 to overcome intratumor oxidative and hypoxic stress for colorectal cancer metastasis.
    Oncogene. 2026 Jun 3. doi: 10.1038/s41388-026-03738.
    

    >> Share

    
    

    
    Oncol Rep

23. YU Q, Luan P, Liang J, Wang L, et al
    Targeting colorectal cancer and T?cell metabolism for the treatment of colorectal cancer (Review).
    Oncol Rep. 2026;56:142.
    

    >> Share

    
    

    
    PLoS One

24. 
    Correction: Asynchronous telerehabilitation in prehabilitation and postoperative recovery for colorectal cancer: A protocol for a randomized controlled trial.
    PLoS One. 2026;21:e0350693.
    

    >> Share

    
    
25. KANDHAVELU J, Subramanian K, Moodley N, Abass KS, et al
    Combinatorial drug repurposing of Valproic acid and Zebularine regulates Kruppel-like factor 4 and beta-catenin expression in colon cancer cells.
    PLoS One. 2026;21:e0348215.
    

    >> Share

    
    
26. SARKER H, Farid FB, Kamrun M, Masud E, et al
    Multi-omics and pan-cancer analysis revealed common molecular signatures to disclose multitargeted anticancer agents through network pharmacology approach.
    PLoS One. 2026;21:e0350614.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share